These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29155495)

  • 41. Opportunities for a chronic disease outreach program in China.
    D'Amico G
    Kidney Int Suppl; 2005 Sep; (98):S46-8. PubMed ID: 16108971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Care of undocumented individuals with ESRD: a national survey of US nephrologists.
    Hurley L; Kempe A; Crane LA; Davidson A; Pratte K; Linas S; Dickinson LM; Berl T
    Am J Kidney Dis; 2009 Jun; 53(6):940-9. PubMed ID: 19327878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care.
    Yong DS; Kwok AO; Wong DM; Suen MH; Chen WT; Tse DM
    Palliat Med; 2009 Mar; 23(2):111-9. PubMed ID: 19153131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [World kidney Day 2008: the impact of epidemiology of kidney diseases in Belgium].
    Nortier J; Peeters P; Collart F; Des Grottes JM; Pochet JM; ;
    Rev Med Brux; 2008; 29(1 Suppl):S19-24. PubMed ID: 18497216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Past, present and future of end-stage renal disease therapy in the United States.
    Uribarri J
    Mt Sinai J Med; 1999 Jan; 66(1):14-9. PubMed ID: 9989100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peritoneal dialysis in China: meeting the challenge of chronic kidney failure.
    Yu X; Yang X
    Am J Kidney Dis; 2015 Jan; 65(1):147-51. PubMed ID: 25446022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health economics of renal replacement therapy: perspectives from Singapore.
    Tan CC; Chan CM; Ho CK; Wong KS; Lee EJ; Woo KT
    Kidney Int Suppl; 2005 Apr; (94):S19-22. PubMed ID: 15752233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and cost of haemodialysis in Jordan.
    Batieha A; Abdallah S; Maghaireh M; Awad Z; Al-Akash N; Batieneh A; Ajlouni KA
    East Mediterr Health J; 2007; 13(3):654-63. PubMed ID: 17687839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in the worldwide epidemiology of peritoneal dialysis.
    Li PK; Chow KM; Van de Luijtgaarden MW; Johnson DW; Jager KJ; Mehrotra R; Naicker S; Pecoits-Filho R; Yu XQ; Lameire N
    Nat Rev Nephrol; 2017 Feb; 13(2):90-103. PubMed ID: 28029154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attitudes of Chinese chief nephrologists toward dialysis modality selection.
    Zhao LJ; Wang T
    Adv Perit Dial; 2003; 19():155-8. PubMed ID: 14763053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The need for dialysis in Haiti: dream or reality?
    Exantus J; Desrosiers F; Ternier A; Métayer A; Abel G; Buteau JH
    Blood Purif; 2015; 39(1-3):145-50. PubMed ID: 25672966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany.
    Weisshaar E; Matterne U; Mettang T
    Nephrol Dial Transplant; 2009 Apr; 24(4):1328-30. PubMed ID: 19155533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The challenges of ESRD care in developing economies: sub-Saharan African opportunities for significant improvement.
    Bamgboye EL
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):18-22. PubMed ID: 27509589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Renal Epidemiology and Information Network: 2006 annual report].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2008 Jul; 4 Suppl 2():S53-167. PubMed ID: 19058350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [REIN annual report 2005. Renal Epidemiology and Information Network & Agence de la biomédecine].
    Couchoud C; Stengel B; Jacquelinet C
    Nephrol Ther; 2007 Apr; 3 Suppl 1():S1-82. PubMed ID: 17703614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.